Vertex to Participate in Upcoming September Investor Conferences
Vertex to Participate in Upcoming September Investor Conferences
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency.BOSTON--(BUSINESS WIRE)--Aug. 22, 2024--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in two upcoming investor conferences.
波士顿--(美国商业资讯)--2024年8月22日--Vertex Pharmicals Incorporated（纳斯达克股票代码：VRTX）今天宣布管理层将参加两次即将举行的投资者会议。
- Dr. Reshma Kewalramani, Chief Executive Officer and President, and Charles Wagner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, 2024 at 11:30 a.m. ET.
- Susie Lisa, Senior Vice President of Investor Relations and Manisha Pai, Executive Director of Investor Relations, will participate in a fireside chat at the Cantor Global Healthcare Conference on Tuesday, September 17, 2024 at 9:10 a.m. ET.
- 首席执行官兼总裁雷什玛·凯瓦尔拉马尼博士和执行副总裁兼首席财务官查尔斯·瓦格纳将于美国东部时间2024年9月5日星期四上午11点30分参加摩根士丹利第22届年度全球医疗保健会议的炉边谈话。
- 投资者关系高级副总裁苏西·丽莎和投资者关系执行董事马尼莎·派将于美国东部时间2024年9月17日星期二上午9点10分参加坎托全球医疗大会的炉边谈话。
A live webcast of management's remarks will be available through the Vertex website, in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website.
管理层讲话的网络直播将通过Vertex网站的 “新闻和事件” 页面下的 “投资者” 部分进行直播。会议网络直播的重播将存档在公司的网站上。
About Vertex
关于 Vertex
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency.
Vertex 是一家全球生物技术公司，投资于科学创新，为严重疾病患者创造变革性药物。该公司已经批准了治疗多种慢性、缩短寿命的遗传疾病（囊性纤维化、镰状细胞病和依赖输血的β地中海贫血）根本原因的药物，并将继续推进这些疾病的临床和研究项目。Vertex还拥有强大的临床研究疗法产品线，涵盖其他严重疾病的各种模式，对人类因果生物学有深刻的见解，包括急性和神经性疼痛、APOL1介导的肾脏疾病、IgA肾病、常染色体显性多囊肾病、1型糖尿病、1型肌强直营养不良症和α-1抗胰蛋白酶缺乏症。
Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia, Latin America and the Middle East. Vertex is consistently recognized as one of the industry's top places to work, including 14 consecutive years on Science magazine's Top Employers list and one of Fortune's 100 Best Companies to Work For. For company updates and to learn more about Vertex's history of innovation, visit or follow us on LinkedIn, Facebook, Instagram, YouTube and Twitter/X.
Vertex 成立于 1989 年，全球总部位于波士顿，国际总部设在伦敦。此外，该公司在北美、欧洲、澳大利亚、拉丁美洲和中东设有研发基地和商业办事处。Vertex 一直被公认为业内最佳工作场所之一，包括连续 14 年入选《科学》杂志的 “杰出雇主” 榜单，并入选《财富》100家最佳工作公司之一。要了解公司最新动态并进一步了解Vertex的创新历史，请在领英、脸书、Instagram、YouTube和Twitter/X上访问或关注我们。
(VRTX-WEB)
（VRTX-WEB）
View source version on businesswire.com:
在 businesswire.com 上查看源版本：
Vertex Pharmaceuticals Incorporated
Vertex 制药公司
Investors:
InvestorInfo@vrtx.com
投资者：
InvestorInfo@vrtx.com
Source: Vertex Pharmaceuticals Incorporated
来源：Vertex 制药公司